Novitra mass launch
This article was originally published in The Tan Sheet
Executive Summary
Santa Rosa, Calif.-based Boericke & Tafel is supporting mass market launch of Novitra cold sore remedy with consumer print, radio ad campaign slated to begin in first quarter 2003. Designed by Stratagem Health Communications (San Francisco), ad push will feature "zoned" approach, starting in the mountain states and Northwest. Novitra 1Web site features educational, promotional materials and coupons. Homeopathic zincum oxydatum cream in .25 oz. tubes retails for approximately $12.99, carries "immediate action" and "clinically proven to shorten the duration of cold sores" claims. Now reaching shelves at Wal-Mart, Target, Novitra also is sold at major food, drug outlets nationwide...
You may also be interested in...
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.